Progressive brain changes in patients with chronic fatigue syndrome: A longitudinal MRI study.
Shan, Zack Y, Kwiatek, Richard, Burnet, Richard et al. · Journal of magnetic resonance imaging : JMRI · 2016 · DOI
Quick Summary
This study used brain MRI scans taken 6 years apart to compare 15 ME/CFS patients with 10 healthy people. Researchers found that patients with ME/CFS had progressive shrinkage of white matter (the brain's communication pathways) in a specific region called the inferior fronto-occipital fasciculus, while healthy controls showed no change. The amount of brain shrinkage in ME/CFS patients correlated with their symptom severity.
Why It Matters
This longitudinal evidence suggests ME/CFS involves progressive neurobiological changes rather than static dysfunction, potentially validating patient experiences of worsening symptoms over time. Identifying specific brain regions affected may eventually enable biomarkers for diagnosis and monitoring of disease progression. Understanding these structural changes strengthens the case that ME/CFS is a biological condition affecting the central nervous system.
Observed Findings
Progressive white matter volume decrease in the left inferior fronto-occipital fasciculus in CFS patients over 6 years, while remaining stable in healthy controls
Decreased regional white matter and gray matter volumes in adjacent and contralateral brain regions in CFS patients compared to controls
Significant positive correlations between regional brain volume changes and CFS symptom severity scores (Bell disability scores and somatic/neurological symptom measures)
No progressive changes in white matter or gray matter in healthy controls over the 6-year period
Inferred Conclusions
ME/CFS is associated with progressive white matter deficits that continue to deteriorate at abnormally elevated rates compared to healthy aging
Brain structural abnormalities in ME/CFS correlate with clinical symptom severity, suggesting a biological basis for reported symptoms
The inferior fronto-occipital fasciculus and connected regions may be key sites of pathophysiology in ME/CFS
Remaining Questions
Do these brain changes precede symptom onset, develop concurrently, or represent secondary effects of prolonged illness?
Are the progressive white matter changes reversible with treatment, or do they represent permanent damage?
What This Study Does Not Prove
This study does not prove that white matter loss causes ME/CFS symptoms—the relationship may be bidirectional or both may result from an underlying process. The small sample size limits generalizability to all ME/CFS patients. The study cannot explain the mechanisms driving these brain changes or whether they are reversible.
Tags
Symptom:Fatigue
Biomarker:Neuroimaging
Method Flag:Weak Case DefinitionSmall SampleExploratory Only